Pfizer Is Predicted To Make $15 Billion In 2021 From Its COVID-19 Vaccine Sales
The global leader in vaccine manufacturing, Pfizer is expecting to earn $15 billion from the sale of their COVID-19 vaccine. It is a quarter of this year’s total revenue. The company has co-developed the vaccine with German drugmakerBioNTech. The company hopes to deliver around 2 million doses of the vaccine to people in 2021. As all the countries are hoping to get the vaccine as soon as possible, the drugmaker giant is determined to deliver the vaccine at a lightning pace. Coronavirus has already killed more than 2…
Read More